MAD-ID 2019


As an attendee of MAD-ID 2019, you will be able to earn up to 18 Continuing Pharmacy Education hours (1.8 CEU). MAD-ID is in the process of arranging for CME and CNE.

At the conclusion of this activity, you should be able to:

Depending on which four classroom/workshop sessions the participant attends, four of the following eight learning objectives should be achieved:

  1. Design effective antimicrobial stewardship strategies for front-line clinicians
  2. Describe implementation and evaluation processes to support antimicrobial stewardship interventions
  3. Apply pharmacokinetic and pharmacodynamic principles for optimization of antibiotic dosing
  4. Explain the use of leadership skills in antimicrobial stewardship practice
  5. Discuss the importance of formulary processes in ensuring appropriate antimicrobial use
  6. Describe the process of developing a business plan to justify new or expanded antimicrobial stewardship services
  7. Explain how data from electronic medical records can be used to evaluate antimicrobial stewardship interventions
  8. Outline antimicrobial interventions to improve patient outcomes

The following learning objective relate to the remaining educational sessions:

  1. Discuss past trends and predict future changes in antimicrobial resistance and stewardship
  2. Explain recommendations from public, government, and regulatory agencies to improve antimicrobial use and reduce resistance
  3. List opportunities to work with nurses and other healthcare professionals to enhance antimicrobial stewardship in new settings, including long term care
  4. Describe the challenges of improving outpatient antimicrobial use and suggest an opportunity for use of point of care testing in primary/urgent care settings
  5. Summarize the evidence for short courses of antimicrobial therapy for common infections and for de-escalation or use of oral agents for gram negative bloodstream infection
  6. List social and behavior drivers of antimicrobial use and describe how patient perspectives can change prescribing behavior
  7. Explain how new microbiological tests and collaboration with microbiology laboratory staff can improve antimicrobial use
  8. Describe the clinical data and place in therapy for new agents to treat bacterial infections
  9. Identify important new literature in infectious diseases and antimicrobial stewardship, and describe the impact of the opioid epidemic on infectious diseases practice